Log in with your email address username.


Important notice

doctorportal Learning is on the move as we will be launching a new website very shortly. If you would like to sign up to dp Learning now to register for CPD learning or to use our CPD tracker, please email support@doctorportal.com.au so we can assist you. If you are already signed up to doctorportal Learning, your login will work in the new site so you can continue to enrol for learning, complete an online module, or access your CPD tracker report.

To access and/or sign up for other resources such as Jobs Board, Bookshop or InSight+, please go to www.mja.com.au, or click the relevant menu item and you will be redirected.

All other doctorportal services, such as Find A Doctor, are no longer available.

[Correspondence] Alpha-chain disease: a lymphomagenesis model

Science is generally more interested in exploring the unknowns and mysteries of the present and future than in commemorating events of the past. However, recalling certain works (ie, apparent breakthroughs in their given field at the time of publication) to measure their contributions and the progress made over the ensuing years, can be useful. In this case, alpha-chain disease is of paramount interest. Thanks to the exemplary collaboration between a clinician, Jean-Claude Rambaud, and a physician scientist in immunology, Maxime Seligmann, the discovery in 1968 of alpha-chain disease1,2 in a young Syrian woman with an abdominal lymphoma led to game-changing outcomes over the following 50 years, including a model of lymphomagenesis that is still in progress.